CIK: 1556270 - Address: C/O Dentsply Sirona Inc, 13320-B Ballantyne Corporate Place, Charlotte, NC 28277
18 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
8/7/24 17:00
8/5/24
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d00.0000082D
2/22/24 17:02
2/21/24
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d100206.9400182D
2/16/24 17:56
2/14/24
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d00.0004582D
2/9/24 17:00
2/7/24
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d81467.850121879D
2/9/24 17:00
2/7/24
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOS.d-6,871572.610-12-1379D
12/6/23 17:01
12/4/23
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d1,06879.540132079D
12/6/23 17:01
12/4/23
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOS.d-3,657513.050-7-879D
9/5/23 17:01
8/31/23
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d1,06879.540132373D
9/5/23 17:01
8/31/23
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOS.d-6,873512.010-13-1673D
8/8/23 17:59
8/5/23
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d00.0000173D
5/5/23 18:00
5/4/23
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d100178.2601173D
2/16/23 18:52
2/14/23
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d00.0004573D
11/16/22 17:00
11/14/22
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d1,17862.000193771D
11/16/22 17:00
11/14/22
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOS.d-4,562434.470-11-1371D
11/9/22 17:00
11/7/22
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d1,24852.000246362D
11/9/22 17:00
11/7/22
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOS.d-5,060382.490-13-1862D
8/8/22 17:00
8/5/22
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d00.0000152D
5/23/22 17:00
5/20/22
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d100141.6001151D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact